The common feature of these two diseases is insulin resistance, and thus some antidiabetic drugs, such as intranasal insulin, pioglitazone, metformin, and liraglutide, are promising drugs that could be useful in the treatment of Alzheimer’s disease [93]. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.